COMPOSITIONS AND APPLICATIONS OF CAROTENOIDS OF IMPROVED ABSORPTION AND BIOAVAILABILITY
First Claim
1. A composition, comprising:
- a solubilizate form of a xanthophyll which does not contain any crystal forms of carotenoids, the xanthophyll solubilizate being in the form of micro-micelles obtained by melting a xanthophyll diacetate or a xanthophyll dipropionate in their natural original lipid vegetable matrix in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture, in a dosage between 2 to 50 mg, wherein the xanthophyll solubilizateprovides an absorption that is at least 20% greater than that of crystalline carotenoids, andprovides an improved bioavailability in the macular pigment deposit that exceeds by at least 10% of the Macular Pigment Optical Density the bioavailability obtained by ingesting crystalline xanthophylls; and
at least one of zinc, copper, selenium, manganese, vitamin A, vitamin C, and vitamin E.
0 Assignments
0 Petitions
Accused Products
Abstract
Micro-micelle forms of carotenoids and/or xanthophylls, which show improved absorption and biovailability by living organisms, provide higher levels of carotenoids in the blood stream, and consequently are deposited at the target tissues at a faster rate and more efficiently than crystalline carotenoids are provided. The micro-micelle forms do not contain any crystal forms of carotenoids, and are obtained as micro-micelles after melting Lutein diacetate or Lutein dipropionate in their natural original lipid vegetable matrix, in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture. The micro-micelle forms can be ingested at a dosage between 2 mg to 50 mg to provide an absorption of the carotenoid solubilizate that is at least 20% above that of crystalline carotenoids, and provides a macular pigment deposit that exceeds at least 10% of Macular Pigment Optical Density, than the deposition obtained by ingesting crystalline Lutein.
2 Citations
18 Claims
-
1. A composition, comprising:
- a solubilizate form of a xanthophyll which does not contain any crystal forms of carotenoids, the xanthophyll solubilizate being in the form of micro-micelles obtained by melting a xanthophyll diacetate or a xanthophyll dipropionate in their natural original lipid vegetable matrix in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture, in a dosage between 2 to 50 mg, wherein the xanthophyll solubilizate
provides an absorption that is at least 20% greater than that of crystalline carotenoids, and provides an improved bioavailability in the macular pigment deposit that exceeds by at least 10% of the Macular Pigment Optical Density the bioavailability obtained by ingesting crystalline xanthophylls; and at least one of zinc, copper, selenium, manganese, vitamin A, vitamin C, and vitamin E. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
- a solubilizate form of a xanthophyll which does not contain any crystal forms of carotenoids, the xanthophyll solubilizate being in the form of micro-micelles obtained by melting a xanthophyll diacetate or a xanthophyll dipropionate in their natural original lipid vegetable matrix in the presence of lipids, phospholipids, fatty acids, emulsifiers and moisture, in a dosage between 2 to 50 mg, wherein the xanthophyll solubilizate
Specification